Biotech

BASi Announces Election of New Director

WEST LAFAYETTE, IN: ...

Pacific Biomarkers Announces the Appointment of Amar A. Sethi, MD, PhD as Its New Chief Scientific Officer

SEATTLE, WA: ...

Peregrine Provides Update on HCV Clinical Program

TUSTIN, CA: Preliminary Data From Phase II Study Shows Antiviral Activity and Positive Safety Profile at Both Bavituximab Doses Evaluated; Supporting Further Dosing and Combination Studies; Company to Seek Collab ...

Miraculins Appoints Chief Financial Officer

WINNIPEG, MANITOBA: ...

Marina Biotech and Mirna Therapeutics Announce License Agreement for the Development of microRNA-Based Therapeutics

BOTHELL, WA and AUSTIN, TX: Mirna Therapeutics Will Develop Oncology-Focused Compounds Utilizing Their Proprietary microRNAs Combined With Marina Biotech's Novel SMARTICLES(R) Liposomal Delivery Technology ...

TiGenix Obtains EUR 2.9 Million FP7 Grant to Fund Development of Cx611 in Rheumatoid Arthritis

LEUVEN, BELGIUM and MADRID, SPAIN: ...

Helix BioPharma Corp. Files Clinical Trial Applications for Its Planned European Phase III Efficacy Trial of Topical Interferon Alpha-2b in Patients With Low-Grade Cervical Lesions

AURORA, ON: ...

Patent Issued for Treatment of Diabetes

DENVER, CO: Omni Bio Pharmaceutical, Inc. Obtains Patent for Diabetes Treatment Through Licensing Partner, Bio Holding, Inc. ...

Pacific Biomarkers Announces Collaborative Agreement With Clinigene International for Providing Specialty Biomarker and High-End Clinical Lab Services to Global Pharmaceutical and Biotechnology Industry

SEATTLE, WA: ...

Dynavax and AstraZeneca Agree to Conduct Toxicology Studies for TLR-9 Agonist for Asthma

BERKELEY, CA: $2.6 Million Payment From AstraZeneca Due to Dynavax ...